Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950133-08-000178
Filing Date
2008-01-16
Accepted
2008-01-16 16:17:27
Documents
2
Group Members
VENROCK ASSOCIATES III, L.P.VENROCK ENTREPRENEURS

Document Format Files

Seq Description Document Type Size
1 SC 13D/A w46722sc13dza.htm SC 13D/A 78389
2 EX-99.A w46722exv99wa.htm EX-99.A 4115
  Complete submission text file 0000950133-08-000178.txt   84587
Mailing Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 301 ISELIN NJ 08830 7324529556
PHARMOS CORP (Subject) CIK: 0000713275 (see all company filings)

EIN.: 363207413 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-35540 | Film No.: 08533634
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112
Business Address ROOM 5508 30 ROCKEFELLER PLAZA NEW YORK NY 10112 2126495600
VENROCK ASSOCIATES (Filed by) CIK: 0000937889 (see all company filings)

EIN.: 136300995 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A